Oldhamianoside�II inhibits prostate cancer progression via regulation of EMT and the Wnt/β‑catenin signaling pathway
2017 ◽
Vol 50
(5)
◽
pp. 1601-1611
◽
CXCR6 Induces Prostate Cancer Progression by the AKT/Mammalian Target of Rapamycin Signaling Pathway
2008 ◽
Vol 68
(24)
◽
pp. 10367-10377
◽
2019 ◽
Vol 25
(18)
◽
pp. 5608-5622
◽